Following this we genotyped the entire Copenhagen City Heart Study (n = 10,604) for variants identified by the initial screening to test whether ABCA3 heterozygotes have reduced lung function or increased risk of COPD. The gene discussed is ABCA3; the disease is chronic obstructive pulmonary disease.